Literature DB >> 27250983

P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.

Yumei Luo1, Cheng Feng1, Jing Wu1, Yongxing Wu2, Dong Liu1, Jie Wu3, Fei Dai1, Jun Zhang4.   

Abstract

BACKGROUND: Previous studies indicated that P2Y1 and P2Y2 receptors, which are widely distributed in the enteric nervous system, are related to pain, while TRPV1 may contribute to visceral pain and hypersensitivity states in irritable bowel syndrome (IBS). Other studies showed that ATP activates the capsaicin-sensitive TRPV1 channel via P2Y receptors. AIM: To detect the expression of P2Y1, P2Y2, and TRPV1 receptors in diarrhea-predominant IBS (IBS-D) patients and analyze any correlations with abdominal pain and to investigate interactions between P2Y receptors and the TRPV1 receptor in IBS-D patients.
METHODS: Rectosigmoid biopsies were collected from patients with IBS-D (n = 36) and healthy controls (n = 15). Abdominal pain was scored using a 10-cm visual analogue scale. Expression levels of P2Y1, P2Y2, and TRPV1 receptors in rectosigmoid biopsies were determined by real-time PCR and double-labeling immunofluorescence with specific antibodies.
RESULTS: Both mRNA and protein expression levels of P2Y1, P2Y2, and TRPV1 receptors were increased in IBS-D compared with controls. Of these receptors, P2Y2 expression correlated with the maximum pain scores (p = 0.02, r = 0.63, Spearman correlation) in IBS-D patients. However, no relationships were detected between P2Y receptors and the TRPV1 receptor.
CONCLUSION: In the present study, we identified an increased expression of P2Y1 and P2Y2 receptors in the rectosigmoid mucosa of IBS-D patients, and P2Y2 correlated with abdominal pain. Furthermore, we identified an increase in TRPV1 expression; however, there were no correlations found between P2Y receptors and the TRPV1 receptor.

Entities:  

Keywords:  Abdominal pain; Irritable bowel syndrome; Purinergic receptor P2Y1; Purinergic receptor P2Y2; TRPV1 receptor

Mesh:

Substances:

Year:  2016        PMID: 27250983     DOI: 10.1007/s10620-016-4211-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

Review 1.  Enteric neuroimmunophysiology and pathophysiology.

Authors:  Jackie D Wood
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

2.  P2Y2 receptors mediate ATP-induced resensitization of TRPV1 expressed by kidney projecting sensory neurons.

Authors:  Hui Wang; Donna H Wang; James J Galligan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-24       Impact factor: 3.619

3.  Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.

Authors:  S Willot; C Gauthier; N Patey; C Faure
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

Review 4.  Novel nervous system mechanisms in visceral pain.

Authors:  B Y De Winter; A Deiteren; J G De Man
Journal:  Neurogastroenterol Motil       Date:  2016-03       Impact factor: 3.598

5.  Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli.

Authors:  Sigrid Elsenbruch; Christina Rosenberger; Ulrike Bingel; Michael Forsting; Manfred Schedlowski; Elke R Gizewski
Journal:  Gastroenterology       Date:  2010-06-22       Impact factor: 22.682

6.  Effect of electroacupuncture on P2X3 receptor regulation in the peripheral and central nervous systems of rats with visceral pain caused by irritable bowel syndrome.

Authors:  Z J Weng; L Y Wu; C L Zhou; C Z Dou; Y Shi; H R Liu; H G Wu
Journal:  Purinergic Signal       Date:  2015-03-26       Impact factor: 3.765

7.  Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior.

Authors:  Sacha A Malin; Derek C Molliver
Journal:  Mol Pain       Date:  2010-04-15       Impact factor: 3.395

8.  Roles of peripheral P2X and P2Y receptors in the development of melittin-induced nociception and hypersensitivity.

Authors:  Zhuo-Min Lu; Fang Xie; Han Fu; Ming-Gang Liu; Fa-Le Cao; Jian Hao; Jun Chen
Journal:  Neurochem Res       Date:  2008-04-11       Impact factor: 3.996

9.  Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?

Authors:  Sander J M van Wanrooij; Mira M Wouters; Lukas Van Oudenhove; Winde Vanbrabant; Stéphanie Mondelaers; Patrick Kollmann; Florian Kreutz; Michael Schemann; Guy E Boeckxstaens
Journal:  Am J Gastroenterol       Date:  2013-11-05       Impact factor: 10.864

10.  Differentiation and migration of bone marrow mesenchymal stem cells transplanted through the spleen in rats with portal hypertension.

Authors:  Song Sun; Gong Chen; Menghua Xu; Yingli Qiao; Shan Zheng
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more
  10 in total

Review 1.  Purinergic drug targets for gastrointestinal disorders.

Authors:  Geoffrey Burnstock; Kenneth A Jacobson; Fievos L Christofi
Journal:  Curr Opin Pharmacol       Date:  2017-11-14       Impact factor: 5.547

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation.

Authors:  Michael Camilleri; Yorick Magnus; Paula Carlson; Xiao Jing Wang; Victor Chedid; Daniel Maselli; Ann Taylor; Sanna McKinzie; Nagaswaroop Kengunte Nagaraj; Irene Busciglio; Asha Nair
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-05-03       Impact factor: 4.871

4.  Gallic Acid Alleviates Visceral Pain and Depression via Inhibition of P2X7 Receptor.

Authors:  Lequan Wen; Lirui Tang; Mingming Zhang; Congrui Wang; Shujuan Li; Yuqing Wen; Hongcheng Tu; Haokun Tian; Jingyi Wei; Peiwen Liang; Changsen Yang; Guodong Li; Yun Gao
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

5.  Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation.

Authors:  Elizabeth J Videlock; Swapna Mahurkar-Joshi; Jill M Hoffman; Dimitrios Iliopoulos; Charalabos Pothoulakis; Emeran A Mayer; Lin Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-22       Impact factor: 4.871

Review 6.  Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.

Authors:  Luis Alberto Bravo-Vázquez; Ixchel Medina-Ríos; Luis David Márquez-Gallardo; Josué Reyes-Muñoz; Francisco I Serrano-Cano; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Asim K Duttaroy; Sujay Paul
Journal:  Dig Dis Sci       Date:  2022-05-04       Impact factor: 3.487

Review 7.  Potential neuro-immune therapeutic targets in irritable bowel syndrome.

Authors:  Maite Casado-Bedmar; Åsa V Keita
Journal:  Therap Adv Gastroenterol       Date:  2020-04-09       Impact factor: 4.409

8.  P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.

Authors:  Jie Wu; Yan Cheng; Rong Zhang; Dong Liu; Yu-Mei Luo; Kun-Lun Chen; Song Ren; Jun Zhang
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

9.  Electroacupuncture Inhibits the Activity of Astrocytes in Spinal Cord in Rats with Visceral Hypersensitivity by Inhibiting P2Y1 Receptor-Mediated MAPK/ERK Signaling Pathway.

Authors:  Jingming Zhao; Hui Li; Chong Shi; Tiezheng Yang; Baoshi Xu
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-25       Impact factor: 2.629

Review 10.  Purinergic Signaling in Endometriosis-Associated Pain.

Authors:  Carla Trapero; Mireia Martín-Satué
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.